World news, news around town, tech update 3
Ad
Friday, 23 September 2016
FDA approves Amgen's cheaper copy of arthritis drug Humira
WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday approved a cheaper, biosimilar version of AbbVie's top-selling arthritis drug, Humira.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment